AN2 Therapeutics, Inc.
ANTXCIK 0001880438 · Every Form 4 filed by insiders at this issuer.
Filings
3
Latest Mar 29, 2024
Unique insiders
2
Showing
3 of 3
Page 1
Top insiders
Most active reporters at AN2 Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Chanda Sanjay | Officer | 2 |
| Zakrzewski Joseph S | Director | 1 |
All filings
3 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 29, 2024 | Chanda Sanjay Chief Development Officer | A | 27,500 | $0.00 | $0 | |
| Mar 18, 2024 | Chanda Sanjay Chief Development Officer | A | 27,500 | $0.00 | $0 | |
| Jan 19, 2024 | Zakrzewski Joseph S Director | S | 100,000 | $19.1141 | $1,911,410 |
Showing 1–3 of 3
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.